Search is restricted to the following diseases: All diseases
General Information:
Id:
717
Diseases:
Alzheimer disease
- [OMIM]
Organism:
Homo sapiens
Tissue/Cell line:
BTO:0000007 HEK-293 cell
Publication type:
article
Reference:
Su Y et al. (2004) Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing Biochemistry 43: 6899-6908
[PMID: 15170327]
Interaction Information:
Comment
Valproic acid (VPA) regulates amyloid-beta precursor protein (APP) processing.
Formal Description Interaction-ID: 4012
Drugbank entries
Show/Hide entries for
Valproic acid
or
APP
Drugbank
DB00313
Drugbank
DB00313
Drugbank
DB00313
Drugbank
DB02235
Drugbank
DB02235
Comment
Lithium lowers the amyloid-beta peptide production.
Formal Description Interaction-ID: 4016
Drugbank entries
Show/Hide entries for
Lithium
Drugbank
DB01356
Drugbank
DB01356
Drugbank
DB01356
Drugbank
DB01356
Drugbank
DB01356
Comment
Valproic acid (VPA) lowers the amyloid-beta peptide production.
Formal Description Interaction-ID: 4017
Drugbank entries
Show/Hide entries for
Valproic acid
Drugbank
DB00313
Drugbank
DB00313
Drugbank
DB00313
Comment
Lithium lowers the amyloid-beta peptide production.
Formal Description Interaction-ID: 10902
Drugbank entries
Show/Hide entries for
Lithium
Drugbank
DB01356
Drugbank
DB01356
Drugbank
DB01356
Drugbank
DB01356
Drugbank
DB01356
Comment
Valproic acid (VPA) lowers the amyloid-beta peptide production.
Formal Description Interaction-ID: 10903
Drugbank entries
Show/Hide entries for
Valproic acid
Drugbank
DB00313
Drugbank
DB00313
Drugbank
DB00313